clearwater analytics enfusion

Enfusion, Clearwater

Clearwater Analytics to buy Enfusion for $11.25 a share

Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately equal mix of cash and stock. Clearwater (NYSE:CWAN) is expected to pay a total of approximately $760M in cash and issue between approximately 23M and 28M new shares to Enfusion (NYSE:ENFN) shareholders.

SiliconANGLE · 3d

Clearwater acquires Enfusion in $1.5B financial software deal

Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock.

Business Insider · 3d

Clearwater Analytics upgraded to Buy at DA Davidson on ‘strategic’ Enfusion deal

DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company’s proposed merger

3don MSN

Clearwater agrees to buy investment management platform Enfusion for $1.5B

Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for ...

Clearwater’s Transformative Acquisition of Enfusion Sparks Buy Rating and Growth Optimism

Clearwater Analytics Holdings (CWAN – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst ...

Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced their entry ...

Crowdfund Insider2d

Clearwater Analytics to Acquire Enfusion, Will Expand Investment Management Platform

Clearwater Analytics (NYSE: CWAN) and Enfusion, Inc. (NYSE: ENFN) announced their entry into a definitive merger agreement.

Traders Magazine3d

Clearwater Analytics to Acquire Enfusion for $1.5 Billion

BOISE, Idaho and CHICAGO, Illinois – January 13, 2025 – Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a ...

10h

Clearwater Analytics upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Michael Infante upgraded Clearwater Analytics (CWAN) to Overweight from Equal Weight with a price target of $34, up from ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results